Palliative sequential chemoradiotherapy for pulmonary sulcus tumor: A case report
- Authors:
- Miki Kikuchi
- Toshihiro Ohtani
- Tomohiro Tamura
- Hiroaki Satoh
View Affiliations
Affiliations: Division of Nursing, Mito Medical Center, University of Tsukuba, Mito, Ibaraki 310‑0015, Japan, Division of Pharmacy, Mito Medical Center, University of Tsukuba, Mito, Ibaraki 310‑0015, Japan, Division of Respiratory Medicine, Mito Medical Center, University of Tsukuba, Mito, Ibaraki 310‑0015, Japan
- Published online on: September 21, 2016 https://doi.org/10.3892/mco.2016.1026
-
Pages:
651-652
Metrics: Total
Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
This article is mentioned in:
Abstract
Pulmonary sulcus tumors are occasionally encountered in non‑small-cell lung cancer (NSCLC) patients. If the patients have a good clinical condition, concurrent chemoradiotherapy is indicated. However, palliative chemotherapy and chemoradiotherapy for patients exhibiting a poor overall condition have not been reported to date. We herein report the case of a 54‑year‑old female patient with a pulmonary sulcus tumor, who had a poor performance status. The patient received sequential chemoradiotherapy, with no severe complications. There was no local recurrence until the time of death, 8 months after the initiation of therapy. Palliative sequential chemoradiotherapy for pulmonary sulcus NSCLC must be effective and carry low risk of complications. Palliative sequential chemoradiotherapy may be considered in certain patients with pulmonary sulcus NSCLC. Either chemotherapy or radiotherapy is administered first and, if there is no apparent deterioration of the patient's general condition, the next treatment modality is administered.
View References
|
1
|
Glassman LR and Hyman K: Pancoast tumor: A
modern perspective on an old problem. Curr Opin Pulm Med.
19:340–343. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Peedell C, Dunning J and Bapusamy A: Is
there a standard of care for the radical management of non-small
cell lung cancer involving the apical chest wall (Pancoast
tumours)? Clin Oncol (R Coll Radiol). 22:334–346. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Laine AM, Westover KD and Choy H:
Radiation therapy as a backbone of treatment of locally advanced
non-small cell lung cancer. Semin Oncol. 41:57–68. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Antoni D and Mornex F: Chemoradiotherapy
of locally advanced nonsmall cell lung cancer: State of the art and
perspectives. Curr Opin Oncol. 28:104–109. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Xu P and Le Pechoux C: Chemoradiotherapy
for stage III non-small cell lung cancer: Have we reached the
limit? Chin Clin Oncol. 4:452015.PubMed/NCBI
|
|
6
|
Topkan E, Yildirim BA, Guler OC, Parlak C,
Pehlivan B and Selek U: Safety and palliative efficacy of
single-dose 8-Gy reirradiation for painful local failure in
patients with stage IV non-small cell lung cancer previously
treated with radical chemoradiation therapy. Int J Radiat Oncol
Biol Phys. 91:774–780. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Dandekar VK, Young J, Kiel K, Bonomi P,
Fidler MJ, Batus M and Sher DJ: Efficacy and tolerability of
palliative split-course thoracic chemoradiotherapy for symptomatic
Non-small cell lung cancer. Am J Clin Oncol. 38:605–609. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sculier JP and Moro-Sibilot D: First- and
second-line therapy for advanced nonsmall cell lung cancer. Eur
Respir J. 33:915–930. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bareschino MA, Schettino C, Rossi A,
Maione P, Sacco PC, Zeppa R and Gridelli C: Treatment of advanced
non small cell lung cancer. J Thorac Dis. 3:122–133.
2011.PubMed/NCBI
|
|
10
|
Thomas A, Liu SV, Subramaniam DS and
Giaccone G: Refining the treatment of NSCLC according to
histological and molecular subtypes. Nat Rev Clin Oncol.
12:511–526. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Gerber DE, Gandhi L and Costa DB:
Management and future directions in non-small cell lung cancer with
known activating mutations. Am Soc Clin Oncol Educ Book. e353–e365.
2014. View Article : Google Scholar : PubMed/NCBI
|
